Three months ended December 31, Year ended December 31, 2023 2022 2023 2022 Net sales $ 8,013 $ 8,079 $ 32,681 $ 34,229 Operating expenses Cost of sales 4,678 4,585 18,477 19,232 Selling, general and administrative expenses 1,625 2,146 21,526 9,049 Research, development and related expenses 467 445 1,842 1,862 (Gain) loss on business divestitures — — (36) (2,724) Goodwill impairment expense — 271 — 271 Total operating expenses 6,770 7,447 41,809 27,690 Operating income (loss) 1,243 632 (9,128) 6,539 Other expense (income), net 243 35 560 147 Income (loss) before income taxes 1,000 597 (9,688) 6,392 Provision (benefit) for income taxes 64 62 (2,691) 612 Income (loss) of consolidated group 936 535 (6,997) 5,780 Income (loss) from unconsolidated subsidiaries, net of taxes 11 8 18 11 Net income (loss) including noncontrolling interest 947 543 (6,979) 5,791 Less: Net income (loss) attributable to noncontrolling interest 2 2 16 14 Net income (loss) attributable to 3M $ 945 $ 541 $ (6,995) $ 5,777 Weighted average 3M common shares outstanding – basic 554.7 551.9 553.9 566.0 Earnings (loss) per share attributable to 3M common shareholders — basic $ 1.70 $ 0.98 $ (12.63) $ 10.21 Weighted average 3M common shares outstanding – diluted 555.4 552.9 553.9 567.6 Earnings (loss) per share attributable to 3M common shareholders — diluted $ 1.70 $ 0.98 $ (12.63) $ 10.18 3M Company and Subsidiaries CONSOLIDATED STATEMENT OF INCOME (LOSS) (Millions, except per-share amounts) (Unaudited) 1 -- 1 of 18 -- December 31, 2023 December 31, 2022 ASSETS Current assets Cash and cash equivalents $ 5,933 $ 3,655 Marketable securities – current 53 238 Accounts receivable – net 4,750 4,532 Inventories 4,822 5,372 Prepaids 485 435 Other current assets 336 456 Total current assets 16,379 14,688 Property, plant and equipment – net 9,159 9,178 Operating lease right of use assets 759 829 Goodwill and intangible assets – net 17,153 17,489 Other assets 7,130 4,271 Total assets $ 50,580 $ 46,455 LIABILITIES AND EQUITY Current liabilities Short-term borrowings and current portion of long-term debt $ 2,947 $ 1,938 Accounts payable 3,245 3,183 Accrued payroll 904 692 Accrued income taxes 365 259 Operating lease liabilities – current 225 261 Other current liabilities 7,611 3,190 Total current liabilities 15,297 9,523 Long-term debt 13,088 14,001 Other liabilities 17,327 8,161 Total liabilities 45,712 31,685 Total equity 4,868 14,770 Shares outstanding December 31, 2023: 552,581,136 December 31, 2022: 549,245,105 Total liabilities and equity $ 50,580 $ 46,455 3M Company and Subsidiaries CONDENSED CONSOLIDATED BALANCE SHEET (Dollars in millions) (Unaudited) 2 -- 2 of 18 -- Year ended December 31, 2023 2022 NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES $ 6,680 $ 5,591 Cash flows from investing activities: Purchases of property, plant and equipment (1,615) (1,749) Purchases and proceeds from sale or maturities of marketable securities and investments – net 194 11 Proceeds from sale of businesses, net of cash sold 60 13 Cash payment from Food Safety business split-off, net of divested cash — 478 Other investing activities 154 201 NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES (1,207) (1,046) Cash flows from financing activities: Change in debt (46) (838) Purchases of treasury stock (33) (1,464) Proceeds from issuances of treasury stock pursuant to stock option and benefit plans 264 381 Dividends paid to shareholders (3,311) (3,369) Other financing activities (21) (60) NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES (3,147) (5,350) Effect of exchange rate changes on cash and cash equivalents (48) (104) Net increase (decrease) in cash and cash equivalents 2,278 (909) Cash and cash equivalents at beginning of year 3,655 4,564 Cash and cash equivalents at end of period $ 5,933 $ 3,655 3M Company and Subsidiaries CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS (Dollars in millions) (Unaudited) 3 -- 3 of 18 -- Three months ended December 31, 2023 Sales Change Analysis By Geographic Area Americas Asia Pacific Europe, Middle East and Africa Worldwide Organic sales 0.2 % (5.5) % (2.9) % (1.9) % Acquisitions 0.4 0.1 0.1 0.3 Divestitures 0.3 (0.4) (0.7) (0.1) Translation 0.4 (0.9) 5.0 0.9 Total sales change 1.3 % (6.7) % 1.5 % (0.8) % Year ended December 31, 2023 Sales Change Analysis By Geographic Area Americas Asia Pacific Europe, Middle East and Africa Worldwide Organic sales 0.4 % (10.5) % (2.2) % (3.2) % Acquisitions 0.3 0.1 — 0.2 Divestitures (0.9) (0.9) (0.9) (0.9) Translation 0.1 (3.2) 1.7 (0.6) Total sales change (0.1) % (14.5) % (1.4) % (4.5) % Three months ended December 31, 2023 Worldwide Sales Change By Business Segment Organic sales Acquisitions Divestitures Translation Total sales change Safety and Industrial (3.9) % — % — % 1.2 % (2.7) % Transportation and Electronics — 1.1 — 0.5 1.6 Health Care (1.0) — (0.4) 1.1 (0.3) Consumer (2.2) — — 0.6 (1.6) Total Company (1.9) 0.3 (0.1) 0.9 (0.8) Year ended December 31, 2023 Worldwide Sales Change By Business Segment Organic sales Acquisitions Divestitures Translation Total sales change Safety and Industrial (5.1) % — % — % (0.5) % (5.6) % Transportation and Electronics (3.5) 0.7 (0.7) (1.0) (4.5) Health Care 0.7 — (3.1) (0.4) (2.8) Consumer (4.7) — (0.1) (0.2) (5.0) Total Company (3.2) 0.2 (0.9) (0.6) (4.5) 4Total sales change is calculated based on reported sales results. The components of sales change include organic local- currency sales, acquisitions, divestitures, and translation. Organic local-currency sales include both organic volume impacts (which excludes acquisition and divestiture impacts) and selling price changes. Acquisition and divestiture impacts are measured separately for the first 12 months post- transaction. 3M Company and Subsidiaries SALES CHANGE ANALYSIS4 (Unaudited) 4 -- 4 of 18 -- 3M discloses business segment operating income (loss) as its measure of segment profit/loss, reconciled to both total 3M operating income (loss) and income (loss) before taxes. Business segment operating income (loss) excludes certain expenses and income that are not allocated to business segments (as described below in “Corporate and Unallocated”). Effective in the first quarter of 2023, the measure of segment operating performance and segment composition used by 3M’s chief operating decision maker (CODM) changed and, as a result, 3M’s disclosed measure of segment profit/loss (business segment operating income (loss)) was updated. The change to business segment operating income (loss) aligns with the update to how the CODM assesses performance and allocates resources for the Company’s business segments. The changes included the items described below. The financial information presented herein reflects the impact of these business segment reporting changes for all periods presented. Reflecting gains/losses from sale of property, plant and equipment (PPE) and other assets within Corporate and Unallocated Change 3M updated its business segment operating performance measure to reflect all gains/losses from sales of PPE and other assets within Corporate and Unallocated. Previously, certain of these gains/losses were included in 3M’s business segments’ operating performance. Movement of certain businesses between segments The businesses associated with two groups of products (each with approximately $25 million in annual sales) were realigned with one moving from the Consumer business segment to the Health Care business segment and the other moving from the Health Care business segment to the Consumer business segment. Also effective in the first quarter of 2023, the Consumer business segment re-aligned from four divisions to the following three divisions: Home, Health and Auto Care; Construction and Home Improvement Markets; and Stationery and Office. BUSINESS SEGMENT INFORMATION Three months ended December 31, Year ended December 31, NET SALES (Millions) 2023 2022 2023 2022 Safety and Industrial $ 2,661 $ 2,735 $ 10,956 $ 11,604 Transportation and Electronics 2,089 2,055 8,501 8,902 Health Care 2,037 2,044 8,195 8,427 Consumer 1,226 1,244 5,026 5,292 Corporate and Unallocated — 1 3 4 Total Company $ 8,013 $ 8,079 $ 32,681 $ 34,229 3M Company and Subsidiaries BUSINESS SEGMENTS (Unaudited) 5 -- 5 of 18 -- BUSINESS SEGMENT INFORMATION Three months ended December 31, Year ended December 31, OPERATING INCOME (LOSS) (Millions) 2023 2022 2023 2022 Safety and Industrial $ 523 $ 563 $ 2,324 $ 1,135 Transportation and Electronics 219 (441) 1,312 973 Health Care 372 412 1,603 1,799 Consumer 221 212 904 978 Total business segment operating income (loss) 1,335 746 6,143 4,885 Corporate and Unallocated Corporate special items: Net costs for significant litigation (76) (65) (14,785) (877) Divestiture costs (137) (54) (496) (60) Gain on business divestitures — — 36 2,724 Divestiture-related restructuring actions — — — (41) Russia exit (charges) benefits — — 18 (109) Total corporate special items (213) (119) (15,227) 1,637 Other corporate (expense) income - net 121 5 (44) 17 Total Corporate and Unallocated (92) (114) (15,271) 1,654 Total Company operating income (loss) 1,243 632 (9,128) 6,539 Other expense/(income), net 243 35 560 147 Income (loss) before income taxes $ 1,000 $ 597 $ (9,688) $ 6,392 Corporate and Unallocated Corporate and Unallocated operating income (loss) includes “corporate special items” and “other corporate expense-net”. Corporate special items include net costs for significant litigation impacting operating income (loss) associated with PFAS- related other environmental and Combat Arms Earplugs matters. In addition, during the voluntary chapter 11 bankruptcy period (which began in July 2022 and ended in June 2023) costs associated with the Aearo portion of respirator mask/asbestos matters were also included in corporate special items. Prior to the bankruptcy, costs associated with Combat Arms Earplugs matters were not included in the Corporate net costs for significant litigation special item, instead being reflected in the Safety and Industrial business segment. Corporate special items also include divestiture costs, gain/loss on business divestitures, divestiture-related restructuring costs, and Russia exit costs/benefits. Divestiture costs include costs related to separating and divesting substantially an entire business segment of 3M following public announcement of its intended divestiture. Other corporate expense-net includes items such as net costs related to limited unallocated corporate staff and centrally managed material resource centers of expertise costs, corporate philanthropic activity, gains/losses from sales of PPE and other assets, and other net costs that 3M may choose not to allocate directly to its business segments. Other corporate expense-net also includes costs and income during the term of transition supply, manufacturing, and service arrangements with divested businesses. Items classified as revenue from this activity are included in Corporate and Unallocated net sales. Because Corporate and Unallocated includes a variety of miscellaneous items, it is subject to fluctuation on a quarterly and annual basis. 3M Company and Subsidiaries BUSINESS SEGMENTS - (CONTINUED) (Unaudited) 6 -- 6 of 18 -- In addition to reporting financial results in accordance with U.S. GAAP, 3M also provides certain non-GAAP measures. These measures are not in accordance with, nor are they a substitute for GAAP measures, and may not be comparable to similarly titled measures used by other companies. Certain measures adjust for the impacts of special items. Special items for the periods presented include the items described in the section entitled “Description of special items”. Because 3M provides certain information with respect to business segments, it is noteworthy that special items impacting operating income (loss) are reflected in Corporate and Unallocated, except as described with respect to net costs for significant litigation and manufactured PFAS products items in the “Description of special items” section. The reconciliations below, therefore, also include impacted segments as applicable. In 2023, 3M changed certain of its non-GAAP measures by adjusting for the results of manufactured PFAS products in arriving at results, adjusted for special items. In the fourth quarter of 2022, 3M recorded a charge for PFAS manufacturing exit costs and included it as an adjustment in arriving at results, adjusted for special items. The 2023 non-GAAP measure change involved expanding the extent of adjustment to include the sales and estimates of income (including exit costs) and associated activity regarding manufactured PFAS products that 3M plans to exit by the end of 2025. This change also impacts other non-GAAP measures such as adjusted free cash flow, adjusted free cash flow conversion and adjusted EBITDA to similarly include relevant special item adjustments for manufactured PFAS products. The information herein reflects the impacts of these changes for all periods presented. This document contains measures for which 3M provides the reported GAAP measure and a non-GAAP measure adjusted for special items. The document also contains additional measures which are not defined under U.S. GAAP. These measures and reasons 3M believes they are useful to investors (and, as applicable, used by 3M) include: GAAP amounts for which a measure adjusted for special items is also provided: Reasons 3M believes the measure is useful • Net sales (and sales change) Considered, in addition to segment operating performance, in evaluating and managing operations; useful in understanding underlying business performance, provides additional transparency to special items • Operating income (loss), segment operating income (loss) and operating income (loss) margin • Income (loss) before taxes • Provision for income taxes and effective tax rate • Net income (loss) • Earnings (loss) per share Additional non-GAAP measures: • Adjusted net cash provided by (used in) operating activities; adjusted purchases of property, plant and equipment (also referred to as adjusted capital expenditures); adjusted free cash flow and adjusted free cash flow conversion Used as indicators of strength and ability to generate cash and as indicator of capital deployment; meaningful as measures of performance • Adjusted EBITDA and adjusted EBITDA margin Considered in evaluating and managing operations; meaningful in analyses of ongoing underlying operating trends • Net debt Meaningful as indicator of liquidity and measure of capital structure strategy The following provides additional information and applicable GAAP amounts reconciled to non-GAAP measures. The term "N/M" used herein references "not meaningful" for certain percent changes. 3M Company and Subsidiaries SUPPLEMENTAL FINANCIAL INFORMATION NON-GAAP MEASURES (Unaudited) 7 -- 7 of 18 -- Certain amounts adjusted for special items (non-GAAP measures): Three months ended December 31, 2022 (Dollars in millions, except per share amounts) Net sales Operating income (loss) Operating income (loss) margin Income (loss) before taxes Provision (benefit) for income taxes Effective tax rate Net income (loss) attributab le to 3M Earnings per diluted share Safety and Industrial GAAP amounts $ 563 20.6 % Adjustments for special items: Net costs for significant litigation (7) Total special items (7) Adjusted amounts (non-GAAP measures)5 $ 556 20.4 % Transportation and Electronics GAAP amounts $ 2,055 $ (441) (21.4) % Adjustments for special items: Manufactured PFAS products (363) 732 Total special items (363) 732 Adjusted amounts (non-GAAP measures)5 $ 1,692 $ 291 17.1 % Total Company GAAP amounts $ 8,079 $ 632 7.8 % $ 597 $ 62 10.5 % $ 541 $ 0.98 Adjustments for special items: Net costs for significant litigation — 58 58 20 38 0.07 Manufactured PFAS products (363) 732 732 147 585 1.05 Divestiture costs — 54 54 11 43 0.08 Total special items (363) 844 844 178 666 1.20 Adjusted amounts (non-GAAP measures)5 $ 7,716 $ 1,476 19.1 % $ 1,441 $ 240 16.6 % $ 1,207 $ 2.18 Three months ended December 31, 2023 (Dollars in millions, except per share amounts) Net sales Sales change Operating income (loss) Operating income (loss) margin Income (loss) before taxes Provision (benefit) for income taxes Effective tax rate Net income (loss) attributab le to 3M Earnings (loss) per diluted share Earnings (loss) per diluted share percent change Safety and Industrial GAAP amounts $ 523 19.6 % Adjustments for special items: Net costs for significant litigation 1 Total special items 1 Adjusted amounts (non-GAAP measures)5 $ 524 19.7 % Transportation and Electronics GAAP amounts $ 2,089 1.6 % $ 219 10.5 % Adjustments for special items: Manufactured PFAS products (320) 151 Total special items (320) 151 Adjusted amounts (non-GAAP measures)5 $ 1,769 4.5 % $ 370 20.9 % Total Company GAAP amounts $ 8,013 (0.8) % $ 1,243 15.5 % $ 1,000 $ 64 6.4 % $ 945 $ 1.70 74% Adjustments for special items: Net costs for significant litigation6 — 77 284 83 201 0.36 Manufactured PFAS products (320) 151 151 38 113 0.20 Gain on business divestitures — — — — — — Divestiture costs — 137 137 52 85 0.16 Total special items (320) 365 572 173 399 0.72 Adjusted amounts (non-GAAP measures)5 $ 7,693 (0.3) % $ 1,608 20.9 % $ 1,572 $ 237 14.9 % $ 1,344 $ 2.42 11 % 3M Company and Subsidiaries SUPPLEMENTAL FINANCIAL INFORMATION NON-GAAP MEASURES – (CONTINUED) (Unaudited) 8 -- 8 of 18 -- Year ended December 31, 2022 (Dollars in millions, except per share amounts) Net sales Operating income (loss) Operating income (loss) margin Income (loss) before taxes Provision (benefit) for income taxes Effective tax rate Net income (loss) attributab le to 3M Earnings per diluted share Safety and Industrial GAAP amounts $ 1,135 9.8 % Adjustments for special items: Net costs for significant litigation 1,414 Total special items 1,414 Adjusted amounts (non-GAAP measures)5 $ 2,549 22.0 % Transportation and Electronics GAAP amounts $ 8,902 $ 973 10.9 % Adjustments for special items: Manufactured PFAS products (1,351) 631 Total special items (1,351) 631 Adjusted amounts (non-GAAP measures)5 $ 7,551 $ 1,604 21.2 % Total Company GAAP amounts $ 34,229 $ 6,539 19.1 % $ 6,392 $ 612 9.6 % $ 5,777 $ 10.18 Adjustments for special items: Net costs for significant litigation — 2,291 2,291 476 1,815 3.20 Manufactured PFAS products (1,351) 631 631 121 510 0.90 Gain on business divestitures — (2,724) (2,724) (39) (2,685) (4.73) Russia exit charges (benefits) — 109 109 (2) 111 0.20 Divestiture-related restructuring actions — 41 41 9 32 0.05 Divestiture costs — 60 60 13 47 0.08 Total special items (1,351) 408 408 578 (170) (0.30) Adjusted amounts (non-GAAP measures)5 $ 32,878 $ 6,947 21.1 % $ 6,800 $ 1,190 17.5 % $ 5,607 $ 9.88 Year ended December 31, 2023 (Dollars in millions, except per share amounts) Net sales Sales change Operating income (loss) Operating income (loss) margin Income (loss) before taxes Provision (benefit) for income taxes Effective tax rate Net income (loss) attributab le to 3M Earnings (loss) per diluted share Earnings (loss) per diluted share percent change Safety and Industrial GAAP amounts $ 2,324 21.2 % Adjustments for special items: Net costs for significant litigation 84 Total special items 84 Adjusted amounts (non-GAAP measures)5 $ 2,408 22.0 % Transportation and Electronics GAAP amounts $ 8,501 (4.5) % $ 1,312 15.4 % Adjustments for special items: Manufactured PFAS products (1,289) 205 Total special items (1,289) 205 Adjusted amounts (non-GAAP measures)5 $ 7,212 (4.5) % $ 1,517 21.0 % Total Company GAAP amounts $ 32,681 (4.5) % $ (9,128) (27.9) % $ (9,688) $ (2,691) 27.8 % $ (6,995) $ (12.63) N/M Adjustments for special items: Net costs for significant litigation6 — 14,869 15,245 3,615 11,630 21.00 Manufactured PFAS products (1,289) 205 205 50 155 0.28 Gain on business divestitures — (36) (36) (11) (25) (0.05) Russia exit charges (benefits) — (18) (18) 3 (21) (0.04) Divestiture costs — 496 496 118 378 0.68 Total special items (1,289) 15,516 15,892 3,775 12,117 21.87 Adjusted amounts (non-GAAP measures)5 $ 31,392 (4.5) % $ 6,388 20.3 % $ 6,204 $ 1,084 17.5 % $ 5,122 $ 9.24 (6) % 5These items represent amounts adjusted for special items. See lead-in to non-GAAP measures discussion. 6For the per share amount, this includes adjusting-out the impact of this item causing weighted average shares outstanding to be the same for both basic and diluted loss per share in periods of resulting net losses. 3M Company and Subsidiaries SUPPLEMENTAL FINANCIAL INFORMATION NON-GAAP MEASURES (Unaudited) 9 -- 9 of 18 -- Q1 2024 forecast 2024 forecast 2024 adjusted earnings per share (non-GAAP measure)5,7 $2.00 to $2.15 $9.35 to $9.75 2024 adjusted effective tax rate (non-GAAP measure)5,7 18.5% to 19.5% 73M provides these forward-looking non-GAAP measures, but cannot, without unreasonable effort, forecast certain items to present or provide a reconciliation to corresponding forecasted GAAP measures. These include special items such as net costs for significant litigation; projected divestiture gains; divestiture costs; divestiture-related restructuring; and net sales and estimates of income and associated activity of exited manufactured PFAS products all of which are subject to limitations in predictability of timing, ultimate outcome and numerous conditions outside of 3M’s control. 3M believes these limitations would result in a range of projected values so broad as to not be meaningful to investors. For these reasons, 3M believes that the probable significance of such information is low. Additionally, for similar reasons, 3M does not include the impact of potentially-divested or acquired businesses on expected operations in forecasted outlook guidance it provides until close of a transaction. Further, at this time, 3M has not selected from the options available to fund amounts due under the PWS and CAE settlements absent receipt of cash payments in the intended spin-off of its Health Care business and, for similar reasons, has not forecasted the impacts of changes in net debt10 (such as incremental net interest expense) that may be needed to fund amounts under these settlements absent the spin. Information with respect to special items for certain historical periods is included in the section entitled “Description of special items”. 3M Company and Subsidiaries SUPPLEMENTAL FINANCIAL INFORMATION NON-GAAP MEASURES (CONTINUED) (Unaudited) 10 -- 10 of 18 -- Three months ended December 31, 2023 Sales Change4 Organic sales Acquisitions Divestitures Translation Total sales change Total Company (1.9) % 0.3 % (0.1) % 0.9 % (0.8) % Remove manufactured PFAS products special item impact 0.5 — — — 0.5 Adjusted total Company (non-GAAP measures)5 (1.4) % 0.3 % (0.1) % 0.9 % (0.3) % Transportation and Electronics — % 1.1 % — % 0.5 % 1.6 % Remove manufactured PFAS products special item impact 2.7 0.2 — — 2.9 Adjusted Transportation and Electronics (non-GAAP measures)5 2.7 % 1.3 % — % 0.5 % 4.5 % By Geographic Area Americas 0.2 % 0.4 % 0.3 % 0.4 % 1.3 % Remove manufactured PFAS products special item impact 0.1 — — 0.1 0.2 Adjusted Americas (non-GAAP measures)5 0.3 % 0.4 % 0.3 % 0.5 % 1.5 % Asia Pacific (5.5) % 0.1 % (0.4) % (0.9) % (6.7) % Remove manufactured PFAS products special item impact (0.3) — — — (0.3) Adjusted Asia Pacific (non-GAAP measures)5 (5.8) % 0.1 % (0.4) % (0.9) % (7.0) % Europe, Middle East & Africa (2.9) % 0.1 % (0.7) % 5.0 % 1.5 % Remove manufactured PFAS products special item impact 2.3 — — 0.1 2.4 Adjusted Europe, Middle East & Africa (non-GAAP measures)5 (0.6) % 0.1 % (0.7) % 5.1 % 3.9 % Year ended December 31, 2023 Sales Change4 Organic sales Acquisitions Divestitures Translation Total sales change Total Company (3.2) % 0.2 % (0.9) % (0.6) % (4.5) % Remove manufactured PFAS products special item impact — — (0.1) 0.1 — Adjusted total Company (non-GAAP measures) (3.2) % 0.2 % (1.0) % (0.5) % (4.5) % Transportation and Electronics (3.5) % 0.7 % (0.7) % (1.0) % (4.5) % Remove manufactured PFAS products special item impact — 0.2 (0.2) — — Adjusted Transportation and Electronics (non-GAAP measures) (3.5) % 0.9 % (0.9) % (1.0) % (4.5) % By Geographic Area Americas 0.4 % 0.3 % (0.9) % 0.1 % (0.1) % Remove manufactured PFAS products special item impact (0.1) — (0.1) — (0.2) Adjusted Americas (non-GAAP measures)5 0.3 % 0.3 % (1.0) % 0.1 % (0.3) % Asia Pacific (10.5) % 0.1 % (0.9) % (3.2) % (14.5) % Remove manufactured PFAS products special item impact (0.4) — — (0.1) (0.5) Adjusted Asia Pacific (non-GAAP measures)5 (10.9) % 0.1 % (0.9) % (3.3) % (15.0) % Europe, Middle East & Africa (2.2) % — % (0.9) % 1.7 % (1.4) % Remove manufactured PFAS products special item impact 0.6 — (0.1) 0.1 0.6 Adjusted Europe, Middle East & Africa (non-GAAP measures)5 (1.6) % — % (1.0) % 1.8 % (0.8) % 3M Company and Subsidiaries SUPPLEMENTAL FINANCIAL INFORMATION NON-GAAP MEASURES (CONTINUED) (Unaudited) 11 -- 11 of 18 -- Full-Year 2024 Forecast Sales Change4 Organic sales Acquisitions Divestitures Translation Total sales change Total Company7 flat to 2% — % — % 0.25 % 0.25 to 2.25% Remove manufactured PFAS products impact7 — % — % — % — % — % Adjusted total Company (non-GAAP measures)5,7 flat to 2% — % — % 0.25 % 0.25 to 2.25% Adjusted net cash provided by (used in) operating activities; adjusted purchases of property, plant and equipment (also referred to as adjusted capital expenditures); adjusted free cash flow and adjusted free cash flow conversion (non- GAAP measures): Three months ended December 31, Year ended December 31, Major GAAP Cash Flow Categories (dollars in millions) 2023 2022 2023 2022 Net cash provided by (used in) operating activities $ 1,986 $ 1,922 $ 6,680 $ 5,591 Net cash provided by (used in) investing activities (301) (388) (1,207) (1,046) Net cash provided by (used in) financing activities (924) (1,315) (3,147) (5,350) Three months ended December 31, Year ended December 31, Adjusted Free Cash Flow (non-GAAP measure) (dollars in millions) 2023 2022 2023 2022 Net cash provided by (used in) operating activities $ 1,986 $ 1,922 $ 6,680 $ 5,591 Adjustments for special items: Net costs for significant litigation after-tax payment impacts 281 178 769 716 Divestiture costs after-tax payment impacts 96 6 313 8 Divestiture gains - closing cost after tax payment impacts — 27 — 27 Divestiture-related restructuring after-tax payment impacts 4 24 11 28 Russia exit charges after-tax payment impacts — — — 2 TCJA transition tax payment — — 126 68 Manufactured PFAS products impact (104) (44) (157) (36) Total adjustments for special items 277 191 1,062 813 Adjusted net cash provided by (used in) operating activities (non-GAAP measure)8 $ 2,263 $ 2,113 $ 7,742 $ 6,404 Purchases of property, plant and equipment (PPE) (358) (506) (1,615) (1,749) Manufactured PFAS products impact - removing related purchases of PPE 50 52 167 175 Adjusted purchases of PPE (non-GAAP measure)8 $ (308) $ (454) $ (1,448) $ (1,574) Adjusted free cash flow (non-GAAP measure)8 $ 1,955 $ 1,659 $ 6,294 $ 4,830 Adjusted net income (loss) attributable to 3M (non-GAAP measure)5 $ 1,344 $ 1,207 $ 5,122 $ 5,607 Adjusted free cash flow conversion (non-GAAP measure)8 145 % 137 % 123 % 86 % 3M Company and Subsidiaries SUPPLEMENTAL FINANCIAL INFORMATION NON-GAAP MEASURES (CONTINUED) (Unaudited) 12 -- 12 of 18 -- (Dollars in billions) Full year 2024 forecast Net cash provided by (used in) operating activities7 $6.5 to $7.1 Adjustments for special items7 — Adjusted net cash provided by (used in) operating activities $6.5 to $7.1 Purchase of property, plant and equipment (PPE) ($1.5 to $1.7) Manufactured PFAS products impact — removing related purchases of PPE ~$0.1 Adjusted purchases of PPE (non-GAAP measure)8 ($1.4 to $1.6) Adjusted free cash flow7,8 $4.9 to $5.7 Net income (loss) attributable to 3M7 $5.2 to $5.4 Adjustments for special items7 — Adjusted net income (loss) attributable to 3M5,7 $5.2 to $5.4 Adjusted free cash flow conversion7,8 95% to 105% 83M defines adjusted net cash provided by (used in) operating activities as net cash provided by operating activities, adjusted for special items. 3M defines adjusted purchases of property, plant and equipment (also referred to as adjusted capital expenditures) as purchases of property, plant and equipment (PPE) adjusted for the estimated impact of such purchases associated with manufactured PFAS products activity. 3M defines adjusted free cash flow as adjusted net cash provided by (used in) operating activities less adjusted purchases of PPE. Cash payments/receipts associated with special items in the determination of adjusted net cash provided by (used in) operating activities are reflected net of applicable tax. For most special items, the cash tax impact is estimated using the U.S. statutory corporate tax rate during the period of payment/receipt. However, the cash tax impact for the portion of payments of costs for significant litigation under the 2023 settlement agreements relative to Combat Arms Earplugs and relative to public water systems regarding PFAS is based on the timing/amount of the actual cash tax deduction (which differs from the timing of the pre-tax settlement payments). 3M defines adjusted free cash flow conversion as adjusted free cash flow divided by net income (loss) attributable to 3M, adjusted for special items. 3M Company and Subsidiaries SUPPLEMENTAL FINANCIAL INFORMATION NON-GAAP MEASURES (CONTINUED) (Unaudited) 13 -- 13 of 18 -- Adjusted EBITDA and adjusted EBITDA margin (non-GAAP measures): Adjusted EBITDA (non-GAAP measure)9 Adjusted EBITDA margin (non-GAAP measure)9 Three months ended December 31, Year ended December 31, Three months ended December 31, Year ended December 31, (Dollars in millions) 2023 2022 2023 2022 2023 2022 2023 2022 Safety and Industrial $ 670 $ 697 $ 2,938 $ 3,115 25.2 % 25.5 % 26.8 % 26.8 % Transportation and Electronics 449 380 1,826 1,946 25.4 % 22.4 % 25.3 % 25.7 % Health Care 520 574 2,200 2,422 25.5 % 28.1 % 26.8 % 28.8 % Consumer 258 249 1,064 1,126 21.1 % 20.0 % 21.2 % 21.3 % Corporate and Unallocated 149 17 119 101 Total Company $ 2,046 $ 1,917 $ 8,147 $ 8,710 26.6 % 24.8 % 26.0 % 26.5 % Three months ended December 31, Year ended December 31, Adjusted EBITDA (non-GAAP measure) (dollars in millions) 2023 2022 2023 2022 Adjusted net sales (non-GAAP measure)5 $ 7,693 $ 7,716 $ 31,392 $ 32,878 Net income (loss) attributable to 3M 945 541 (6,995) 5,777 Add/(subtract): Net income/(loss) attributable to noncontrolling interest 2 2 16 14 (Income)/loss from unconsolidated subsidiaries, net of taxes (11) (8) (18) (11) Provision for income taxes 64 62 (2,691) 612 Other expense/(income): Interest (Income)/expense 279 84 689 395 Pension & OPEB non-service cost (benefit) (36) (49) (129) (248) Depreciation and amortization (DA) expense 537 460 1,987 1,831 Adjustments for special items: Net costs for significant litigation 77 58 14,869 2,291 Manufactured PFAS products impact: Remove manufactured PFAS products operating (income) loss 151 732 205 631 Subtract PFAS-related amount included in DA above (99) (19) (228) (68) Gain on business divestitures — — (36) (2,724) Divestiture-related restructuring actions — — — 41 Russia exit charges (benefits) — — (18) 109 Divestiture costs 137 54 496 60 Total special items 266 825 15,288 340 Adjusted EBITDA (non-GAAP measure)9 $ 2,046 $ 1,917 $ 8,147 $ 8,710 Adjusted EBITDA margin (non-GAAP measure)9 26.6 % 24.8 % 26.0 % 26.5 % 93M defines adjusted EBITDA as net income (loss) attributable to 3M, adjusted for net income/(loss) attributable to noncontrolling interest, (income)/loss from unconsolidated subsidiaries, provision for income taxes, other expense/(income), depreciation and amortization expense, and special items. For business segments, 3M defines adjusted EBITDA as business segment operating income (loss) (3M’s measure of segment operating performance) adjusted for special items that is then further adjusted for depreciation and amortization (DA) expense, net of the PFAS-related amount included in DA. The Company defines adjusted EBITDA margin as adjusted EBITDA divided by net sales, adjusted for special items. 3M Company and Subsidiaries SUPPLEMENTAL FINANCIAL INFORMATION NON-GAAP MEASURES (CONTINUED) (Unaudited) 14 -- 14 of 18 -- Adjusted EBITDA (non-GAAP measure) Three months ended December 31, 2023 (dollars in millions) Safety and Industrial Transportation and Electronics Health Care Consumer Corporate and Unallocated Total Company Adjusted net sales (non-GAAP measure)5 $ 2,661 $ 1,769 $ 2,037 $ 1,226 $ — $ 7,693 Business segment operating income (loss) (measure of segment operating performance), adjusted for special items (non-GAAP measure)5 $ 524 $ 370 $ 372 $ 221 $ 121 $ 1,608 Add/(subtract): Add depreciation and amortization (DA) expense 146 178 148 37 28 537 Subtract PFAS-related amount included in DA above — (99) — — — (99) Adjusted EBITDA (non-GAAP measure)9 $ 670 $ 449 $ 520 $ 258 $ 149 $ 2,046 Adjusted EBITDA margin (non-GAAP measure)9 25.2 % 25.4 % 25.5 % 21.1 % 26.6 % Adjusted EBITDA (non-GAAP measure) Three months ended December 31, 2022 (dollars in millions) Safety and Industrial Transportation and Electronics Health Care Consumer Corporate and Unallocated Total Company Adjusted net sales (non-GAAP measure)5 $ 2,735 $ 1,692 $ 2,044 $ 1,244 $ 1 $ 7,716 Business segment operating income (loss) (measure of segment operating performance), adjusted for special items (non-GAAP measure)5 $ 556 $ 291 $ 412 $ 212 $ 5 $ 1,476 Add/(subtract): Add depreciation and amortization (DA) expense 141 108 162 37 12 460 Subtract PFAS-related amount included in DA above — (19) — — — (19) Adjusted EBITDA (non-GAAP measure)9 $ 697 $ 380 $ 574 $ 249 $ 17 $ 1,917 Adjusted EBITDA margin (non-GAAP measure)9 25.5 % 22.4 % 28.1 % 20.0 % 24.8 % 3M Company and Subsidiaries SUPPLEMENTAL FINANCIAL INFORMATION NON-GAAP MEASURES (CONTINUED) (Unaudited) 15 -- 15 of 18 -- Adjusted EBITDA (non-GAAP measure) Year ended December 31, 2023 (dollars in millions) Safety and Industrial Transportation and Electronics Health Care Consumer Corporate and Unallocated Total Company Adjusted net sales (non-GAAP measure)5 $ 10,956 $ 7,212 $ 8,195 $ 5,026 $ 3 $ 31,392 Business segment operating income (loss) (measure of segment operating performance), adjusted for special items (non-GAAP measure)5 $ 2,408 $ 1,517 $ 1,603 $ 904 $ (44) $ 6,388 Add/(subtract): Add depreciation and amortization (DA) expense 530 537 597 160 163 1,987 Subtract PFAS-related amount included in DA above — (228) — — — (228) Adjusted EBITDA (non-GAAP measure)9 $ 2,938 $ 1,826 $ 2,200 $ 1,064 $ 119 $ 8,147 Adjusted EBITDA margin (non-GAAP measure)9 26.8 % 25.3 % 26.8 % 21.2 % 26.0 % Adjusted EBITDA (non-GAAP measure) Year ended December 31, 2022 (dollars in millions) Safety and Industrial Transportation and Electronics Health Care Consumer Corporate and Unallocated Total Company Adjusted net sales (non-GAAP measure)5 $ 11,604 $ 7,551 $ 8,427 $ 5,292 $ 4 $ 32,878 Business segment operating income (measure of segment operating performance), adjusted for special items (non-GAAP measure)5 $ 2,549 $ 1,604 $ 1,799 $ 978 $ 17 $ 6,947 Add/(subtract): Add depreciation and amortization (DA) expense 566 410 623 148 84 1,831 Subtract PFAS-related amount included in DA above — (68) — — — (68) Adjusted EBITDA (non-GAAP measure)9 $ 3,115 $ 1,946 $ 2,422 $ 1,126 $ 101 $ 8,710 Adjusted EBITDA margin (non-GAAP measure)9 26.8 % 25.7 % 28.8 % 21.3 % 26.5 % Net debt (non-GAAP measure): Net Debt (non-GAAP measure) December 31, 2023 December 31, 2022 Total debt $ 16,035 $ 15,939 Less: Cash, cash equivalents and marketable securities 6,006 3,916 Net debt (non-GAAP measure)10 $ 10,029 $ 12,023 10The Company defines net debt as total debt less the total of cash, cash equivalents and current and long-term marketable securities. 3M Company and Subsidiaries SUPPLEMENTAL FINANCIAL INFORMATION NON-GAAP MEASURES (CONTINUED) (Unaudited) 16 -- 16 of 18 -- Description of special items: In addition to reporting financial results in accordance with U.S. GAAP, the Company also provides various non-GAAP measures that incorporate adjustments for the impacts of special items. Special items incorporated in the preparation of these non-GAAP measures for the periods presented include the items described below: Net costs for significant litigation: • These relate to 3M's respirator mask/asbestos (which include Aearo and non-Aearo items), PFAS-related other environmental, and Combat Arms Earplugs matters. Net costs include the impacts of changes in accrued liabilities (including interest imputation on applicable settlement obligations), external legal fees, and insurance recoveries, along with the associated tax impacts. These costs also include the impact on the determination of earnings per diluted share of 3M’s option to satisfy a portion of amounts under the Combat Arms Earplugs settlement in shares. 3M does not consider the elements of the net costs associated with these matters to be normal, operating expenses related to the Company’s ongoing operations, revenue generating activities, business strategy, industry, and regulatory environment. Net costs related to respirator mask/asbestos are reflected as special items in the Safety and Industrial business segment while those impacting operating income (loss) associated with PFAS-related other environmental and Combat Arms Earplugs matters are reflected as corporate special items in Corporate and Unallocated. In addition, during the voluntary chapter 11 bankruptcy period (which began in July 2022 and ended in June 2023), costs associated with the Aearo portion of respirator mask/asbestos matters were reflected in corporate special items in Corporate and Unallocated. Prior to the bankruptcy, costs associated with Combat Arms Earplugs matters were reflected as part of special items in the Safety and Industrial business segment. In the fourth quarter of 2023 and 2022, 3M made payments of approximately $355 million and $226 million, respectively, related to net costs for significant litigation. In the full year of 2023 and 2022, 3M made payments of approximately $973 million and $907 million, respectively, related to net costs for significant litigation. Divestiture costs: • These include costs related to separating and divesting substantially an entire business segment of 3M following public announcement of its intended divestiture. In the fourth quarter of 2023 and 2022, 3M made payments of approximately $121 million and $8 million, respectively, associated with divestiture costs. In the full year of 2023 and 2022, 3M made payments of approximately $396 million and $11 million, respectively, associated with divestiture costs. Gain/loss on sale of businesses: • In the third quarter of 2023, 3M recorded a gain related to the sale of its dental local anesthetic business partially offset by a loss associated with a previously contingent indemnification obligation from a 2020 divestiture. • In the third quarter of 2022, 3M recorded a gain related to the split-off and combination of its Food Safety business with Neogen Corporation. In the fourth quarter and full year of 2022, 3M made payments of approximately $34 million related to closing costs of the transaction that were part of the determination of the gain thereon. Russia exit charges/benefits: • In the second quarter of 2023, 3M recorded a gain on final disposal of net assets in Russia. Previously, in the third quarter of 2022, 3M recorded a charge primarily related to impairment of these assets in connection with management's committed exit and disposal plan. In the fourth quarter and full year of 2022, 3M made payments of approximately $1 million and $3 million, respectively, related to Russia exit charges. Divestiture-related restructuring actions: • In the third quarter of 2022, following the split-off of the Food Safety business, management approved and committed to undertake certain restructuring actions addressing corporate functional costs across 3M in relation to the magnitude of amounts previously allocated to the divested business. In the fourth quarter of 2023 and 2022 , 3M made payments of approximately $5 million and $29 million, respectively, associated with divestiture-related restructuring actions. In the full year of 2023 and 2022, 3M made payments of approximately $14 million and $34 million, respectively, associated with divestiture-related restructuring actions. Enactment/measurement period adjustments related to the Tax Cuts and Jobs Act (TCJA) • In the full year of 2023 and 2022, 3M made payments of approximately $126 million and $68 million, related to the transition tax expense incurred as a result of the 2017 enactment of the TCJA. 3M Company and Subsidiaries SUPPLEMENTAL FINANCIAL INFORMATION NON-GAAP MEASURES (CONTINUED) (Unaudited) 17 -- 17 of 18 -- Manufactured PFAS products: • These amounts relate to sales and estimates of income (loss) and associated activity regarding manufactured PFAS products that 3M plans to exit by the end of 2025 included within the Transportation and Electronics business segment. Estimated income does not contemplate impacts on non-operating items such as net interest income/expense and the non- service cost components portion of defined benefit plan net periodic benefit costs. Relative to the impact of the activity of manufactured PFAS products on cash provided by (used in) operating activities, amounts are based on estimates of associated income, depreciation/amortization, certain changes in working capital and accruals, and timing of associated payments. 3M Company and Subsidiaries SUPPLEMENTAL FINANCIAL INFORMATION NON-GAAP MEASURES (CONTINUED) (Unaudited) 18 -- 18 of 18 --